TABLE 2.
Screening Rates at Baseline
| % of patients | |||||
|---|---|---|---|---|---|
| Characteristic | African American (n = 295) |
Native American (n = 371) |
White (n = 226) |
All (n = 892) |
P valuea |
| Mammography | |||||
| Never | 28 | 19 | 26 | 24 | 0.003 (African American vs. white 0.054; African American vs. Native American < 0.001) |
| Within last 3 yrs | 60 | 59 | 54 | 58 | |
| > 3 yrs ago | 13 | 22 | 21 | 19 | |
| Pap test | |||||
| Never | 1 | 2 | 1 | 2 | 0.535 |
| Within last 3 yrs | 83 | 81 | 79 | 81 | |
| > 3 yrs ago | 16 | 16 | 20 | 17 | |
| Clinical breast examination | |||||
| Never | 6 | 9 | 8 | 8 | 0.589 |
| Within last yr | 50 | 51 | 48 | 50 | |
| > 1 yr ago | 44 | 40 | 45 | 43 | |
Pap: Papanicolaou.
P values from chi-square tests (two-sided) for overall race effect followed by pairwise comparisons between races. A significance level of 0.05 was used for the overall race comparisons. Bonferroni adjustments created a significance level of 0.05/3 = 0.0167 for each pairwise comparison.